Webinar: Demeter EVPrep Demonstrates Compatibility with Mass Spectrometry Proteomic Analysis

EXOKĒRYX^TM invites you to our upcoming webinar to learn more about the evaluation of our Demeter EVPrep^TM automated EV isolation technology and compatibility with mass spectrometry proteomic analysis by researchers at The Scripps Research Institute.

• What: Webinar presentation
• Who: EV researchers who conduct proteomic analysis and need better EV isolation and faster time to discovery
• When: April 8, 2026,10:00am Pacific Time

The success of EV research depends on scalable, automated, reproducible isolation methods that consistently produce high recovery of pure EVs. Conventional EV isolation methods miss the mark, forcing a tradeoff between purity and recovery and producing unreliable results. In this webinar presentation:

1. Dr. Amber Murray, Chief Scientific Officer at EXOKĒRYX, will give a technology overview of our Demeter EVPrep automated EV isolation system.
2. Dr. Anthony Balistreri, a Postdoctoral Associate at The Scripps Research Institute, will share some of his challenges with traditional EV isolation methods in his Alzheimer's disease research, why he chose to try out Demeter EVPrep, and the results of a limited technology evaluation study that looked at Demeter EVPrep's ability to produce pure EV eluates compatible with mass spectrometery proteomic analysis and to isolate EVs containing Alzheimer's disease biomarkers.
3. Dr. Natalie Turner (of The rEView Podcast fame), also from The Scripps Research Institute, will provide a deeper dive into the mass spectrometry analysis and results.